Marta Anna Kowalik

YAP activation is an early event and a potential therapeutic target in liver cancer development

Andrea Perra, Marta Anna Kowalik, Elena Ghiso et al. · Journal of Hepatology · 2014 · 253 citations · Full text

Potential Therapeutic Target, Tumor Biology, Signal Transduction +14

Thyroid hormone (T3) and TRβ agonist GC‐1 inhibit/reverse nonalcoholic fatty liver in rats

Andrea Perra, Gabriella Simbula, Michela Simbula et al. · The FASEB Journal · 2008 · 143 citations

Gc‐1 Inhibit/reverse, Fatty Liver Disease, Obesity +18

Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience

Roberto Littera, Marcello Campagna, Silvia Deidda et al. · Frontiers in Immunology · 2020 · 136 citations · Full text

MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC)

Annalisa Petrelli, Andrea Perra, Davide Corà et al. · Hepatology · 2013 · 120 citations · Full text

Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis

Marta Anna Kowalik, Giulia Guzzo, Andrea Morandi et al. · Oncotarget · 2016 · 96 citations · Full text